Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Gynecol Oncol. 2013 Apr 28;130(2):334–339. doi: 10.1016/j.ygyno.2013.04.053

Table 1.

Characteristics of Endometrial Cancer Cases and Controls, 2002-2006, Alberta, Canada

Characteristics Cases
(n = 519)
Controls
(n = 1,015)
N % N %
Age at diagnosis/reference date, years
 < 40 11 2.1 38 3.7
 40–49 66 12.7 127 12.5
 50–59 204 39.3 376 37.1
 60–69 170 32.8 339 33.4
 70+ 68 13.1 135 13.3
Residential status
 Urban 349 67.2 652 64.2
 Rural 170 32.8 363 35.8
Education
 High school diploma or less 169 32.5 288 28.4
 Non-university certificate 237 45.7 483 47.6
 University degree 113 21.8 243 23.9
 Unknown 0 0 1 0.1
Marital status
 Never married 40 7.7 23 2.3
 Ever married 479 92.3 992 97.7
Age at menarche, years of age
 ≤ 12 306 59.0 508 50.1
 > 12 213 41.0 507 49.9
Oral Contraception
 Never, < 6 months 212 40.5 296 29.2
 Ever 305 58.2 709 69.9
  6 – 59 months 170 32.4 349 34.4
  60+ months 135 25.8 359 35.4
  Unknown duration 0 0 1 0.1
 Unknown hormone type 7 1.3 10 1.0
Parity
 0 93 17.9 105 10.3
 1–2 225 43.4 418 41.2
 3+ 201 38.7 492 48.5
BMI, kg/m2
 <18.5 3 0.6 9 0.9
 18.5–24.9 90 17.3 320 31.5
 25–29.9 137 26.4 375 37.0
 30+ 289 55.7 310 30.5
 Unknown 0 0 1 0.1
Smoking status
 Never 261 50.3 520 51.2
 Former 196 37.8 367 36.2
 Current 62 11.9 128 12.6
 Age at Menopause
 ≥ 50 254 63.7 436 59.6
 < 50 145 36.3 296 40.4
Menopausal hormone therapya
 Never use, < 6 months 235 58.9 362 49.5
 Estrogen only 18 4.5 23 3.1
 E+P continuous combined only 42 10.5 162 22.1
  6 – 59 months 22 5.5 61 8.3
  60+ months 20 5.0 101 13.8
 Other combinations 103 25.8 180 24.6
 Unknown hormone therapy type 1 0.3 5 0.7

BMI, body mass index; E+P, estrogen plus progesterone; IUD, intra-uterine device

a

Restricted to post-menopausal women (n=399 cases, n=732 controls).